Abstract | PURPOSE: METHODS: Rat NCLDH models by autologous nucleus pulposus implantation to dorsal root ganglion were established. Vehicle or Bay 60-7550 (0.1, 1.0 mg/kg) was injected by intrathecal catheter at day 1 post-operation. The ipsilateral mechanical withdrawal thresholds were analyzed from the day before surgery to day 7 after surgery. At day 7 post-operation, the ipsilateral lumbar (L4-L6) segments of the spinal dorsal horns were removed, and tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), cyclic adenosine monophosphate (cAMP), and cyclic guanosine monophosphate (cGMP) expressions were measured by ELISA. Furthermore, PDE2A mRNA and protein expressions in spinal cord were measured by Real-Time PCR and Western blot. RESULTS: Intrathecal administration of the PDE2A inhibitor Bay 60-7550, significantly attenuated mechanical allodynia, down-regulated spinal TNF-α, IL-1β and IL-6 over-expressions, increased the expression of spinal cAMP, as well as cGMP in a more remarkable manner, and decreased the spinal PDE2A expression in NCLDH rats in a dose-dependent manner. CONCLUSIONS:
|
Authors | Jun-Nan Wang, Xue-Jun Zhao, Zhi-Hua Liu, Xu-Li Zhao, Tao Sun, Zhi-Jian Fu |
Journal | European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
(Eur Spine J)
Vol. 26
Issue 7
Pg. 1961-1968
(07 2017)
ISSN: 1432-0932 [Electronic] Germany |
PMID | 28283839
(Publication Type: Journal Article)
|
Chemical References |
- 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one
- Anti-Inflammatory Agents
- Biomarkers
- Imidazoles
- Triazines
- Cyclic Nucleotide Phosphodiesterases, Type 2
|
Topics |
- Animals
- Anti-Inflammatory Agents
(therapeutic use)
- Biomarkers
(metabolism)
- Blotting, Western
- Cyclic Nucleotide Phosphodiesterases, Type 2
(antagonists & inhibitors)
- Enzyme-Linked Immunosorbent Assay
- Hyperalgesia
(drug therapy, etiology, metabolism)
- Imidazoles
(therapeutic use)
- Injections, Spinal
- Intervertebral Disc Displacement
(complications, drug therapy, metabolism)
- Male
- Random Allocation
- Rats
- Rats, Wistar
- Real-Time Polymerase Chain Reaction
- Spinal Cord
(metabolism)
- Treatment Outcome
- Triazines
(therapeutic use)
|